Tyler Dylanhyde Net Worth & Insider Trades
Tyler Dylanhyde - Chief Legal Officer, Crispr Therapeutics Ag
What is Tyler Dylanhyde's Net Worth?
The current estimated net worth of Crispr Therapeutics Ag's Chief Legal Officer, Tyler Dylanhyde, is estimated to be about $9.54M . Tyler Dylanhyde owns about 25,204 units of Crispr Therapeutics Ag common stock. In the last year at Crispr Therapeutics Ag, Tyler Dylanhyde has sold an estimated value of $4.83M worth.
What is Tyler Dylanhyde's Past Insider Trading?
Tyler Dylanhyde's largest purchase order was 21,000 units , worth over $263.97K on January 18, 2018. Tyler Dylanhyde's largest sale order was 66,000 units , worth over $1.85M on January 18, 2018. In total, Tyler Dylanhyde has made about 10 transactions over a year of their time at Crispr Therapeutics Ag. Tyler Dylanhyde usually trades in January, with the busiest year in 2017.
Tyler DylanHyde
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Tyler Dylanhyde's' Mailing Address?
- Mailing address is C/o Crispr Therapeutics Ag 200 Sidney Street Cambridge MA 02139 MA
What are Crispr Therapeutics Ag's Past Insider Trades?
Crispr Therapeutics Ag's most recent insider trade came on June 1, 2023 by Samarth Kulkarni who sold 25,000 units worth $1.62M . In the last 7 years, insiders at Crispr Therapeutics Ag have sold an estimated value of $402.48M and bought an estimated value of $60.43M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are Samarth Kulkarni, Chief Executive Officer, Phd Bradley Bolzon, Director, and Rodger Novak, President .
CRISPR Therapeutics AG Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||